U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Substance Class Protein
Created
by admin
on Sat Dec 16 17:11:11 GMT 2023
Edited
by admin
on Sat Dec 16 17:11:11 GMT 2023
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG4
Sequence Origin HUMAN
Sequence Type COMPLETE
Record UNII
86780VJI1Q
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Patritumab
INN   WHO-DD  
USAN   INN  
Official Name English
Immunoglobulin G1, anti-(human neuregulin receptor HER3) (human monoclonal U3-1287 heavy chain), disulfide with human monoclonal U3-1287 κ-chain, dimer
Common Name English
PATRITUMAB [USAN]
Common Name English
Patritumab [WHO-DD]
Common Name English
AMG-888
Code English
AMG888
Code English
patritumab [INN]
Common Name English
U-31287
Code English
U3-1287
Code English
Immunoglobulin G1-kappa, anti-[Homo sapiens ERBB3 (receptor tyrosine-protein kinase erbB-3, HER3)], Homo sapiens monoclonal antibody; gamma1 heavy chain (1-447) [Homo sapiens VH (IGHV4-34*01 (99.00%) -(IGHD)-IGHJ2*01) [8.7.11] (1-117) -IGHG1*03 (118-447)
Common Name English
U31287
Code English
Classification Tree Code System Code
NCI_THESAURUS C20401
Created by admin on Sat Dec 16 17:11:12 GMT 2023 , Edited by admin on Sat Dec 16 17:11:12 GMT 2023
Code System Code Type Description
ChEMBL
CHEMBL2109396
Created by admin on Sat Dec 16 17:11:12 GMT 2023 , Edited by admin on Sat Dec 16 17:11:12 GMT 2023
PRIMARY
ChEMBL
CHEMBL2109406
Created by admin on Sat Dec 16 17:11:12 GMT 2023 , Edited by admin on Sat Dec 16 17:11:12 GMT 2023
PRIMARY
CAS
1361109-68-3
Created by admin on Sat Dec 16 17:11:12 GMT 2023 , Edited by admin on Sat Dec 16 17:11:12 GMT 2023
ALTERNATIVE
CAS
1262787-83-6
Created by admin on Sat Dec 16 17:11:12 GMT 2023 , Edited by admin on Sat Dec 16 17:11:12 GMT 2023
PRIMARY
FDA UNII
86780VJI1Q
Created by admin on Sat Dec 16 17:11:12 GMT 2023 , Edited by admin on Sat Dec 16 17:11:12 GMT 2023
PRIMARY
USAN
KL-232
Created by admin on Sat Dec 16 17:11:12 GMT 2023 , Edited by admin on Sat Dec 16 17:11:12 GMT 2023
PRIMARY
INN
9549
Created by admin on Sat Dec 16 17:11:12 GMT 2023 , Edited by admin on Sat Dec 16 17:11:12 GMT 2023
PRIMARY
NCI_THESAURUS
C78853
Created by admin on Sat Dec 16 17:11:12 GMT 2023 , Edited by admin on Sat Dec 16 17:11:12 GMT 2023
PRIMARY
DRUG BANK
DB12090
Created by admin on Sat Dec 16 17:11:12 GMT 2023 , Edited by admin on Sat Dec 16 17:11:12 GMT 2023
PRIMARY
WIKIPEDIA
Patritumab
Created by admin on Sat Dec 16 17:11:12 GMT 2023 , Edited by admin on Sat Dec 16 17:11:12 GMT 2023
PRIMARY
From To
1_22 1_95
1_144 1_200
1_261 1_321
1_367 1_425
2_22 2_95
2_144 2_200
2_261 2_321
2_367 2_425
3_23 3_94
3_140 3_200
4_23 4_94
4_140 4_200
1_220 3_220
2_220 4_220
1_226 2_226
1_229 2_229
Glycosylation Link Type Site
N 1_297
N 2_297
Related Record Type Details
Patritumab Deruxtecan
DERIVATIVE -> PARENT
RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3
TARGET -> INHIBITOR
Related Record Type Details
Patritumab
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
Molecular Formula CHEMICAL
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966